[
    [
        {
            "time": "2018-07-26",
            "original_text": "Aduro (ADRO) Q2 Loss Narrower Than Expected, Revenues Miss",
            "features": {
                "keywords": [
                    "Q2",
                    "Loss",
                    "Narrower",
                    "Expected",
                    "Revenues",
                    "Miss"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-08-02",
            "original_text": "TESARO (TSRO) Misses Earnings and Revenue Estimates in Q2",
            "features": {
                "keywords": [
                    "TESARO",
                    "Misses",
                    "Earnings",
                    "Revenue",
                    "Estimates",
                    "Q2"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 2,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-24",
            "original_text": "Eli Lillyâ€™s Q2 2018 Earnings: New Products",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Q2",
                    "2018",
                    "Earnings",
                    "New",
                    "Products"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]